These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18756540)

  • 1. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
    Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
    Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
    Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
    Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
    Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
    Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.
    Olatunya OS; Albuquerque DM; Akanbi GO; Aduayi OS; Taiwo AB; Faboya OA; Kayode TS; Leonardo DP; Adekile A; Costa FF
    BMC Med Genet; 2019 Oct; 20(1):160. PubMed ID: 31619193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
    AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
    PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
    Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
    Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
    Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.
    Chaouch L; Talbi E; Moumni I; Ben Chaabene A; Kalai M; Chaouachi D; Mallouli F; Ghanem A; Abbes S
    Dis Markers; 2013; 35(2):67-72. PubMed ID: 24167350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
    Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.
    Heeney MM; Howard TA; Zimmerman SA; Ware RE
    J Lab Clin Med; 2003 Apr; 141(4):279-82. PubMed ID: 12677174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UGT1A1 (TA)n genotyping in sickle-cell disease: high resolution melting (HRM) curve analysis or direct sequencing, what is the best way?
    Thomas V; Mazard B; Garcia C; Lacan P; Gagnieu MC; Joly P
    Clin Chim Acta; 2013 Sep; 424():258-60. PubMed ID: 23827693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
    Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
    Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of genetic variation at the promoter and exon1 of UGT1A1 in occurrence of cholelithiasis in Tunisia.
    Chaouch L; Said Y; Moumni I; Mahjoubi I; Chaabene AB; Darragi I; Ghanem A; Abbes S
    Ann Biol Clin (Paris); 2012; 70(6):702-6. PubMed ID: 23207817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of UDP-glucuronosyltransferase 1A1 promoter region (TA)7 polymorphism in newborns and it's relation with jaundice.
    Muslu N; Turhan AB; Eskandari G; Atici A; Ozturk OG; Kul S; Atik U
    J Trop Pediatr; 2007 Feb; 53(1):64-8. PubMed ID: 17166930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies.
    Italia KY; Jijina FF; Jain D; Merchant R; Nadkarni AH; Mukherjee M; Ghosh K; Colah RB
    Clin Biochem; 2010 Nov; 43(16-17):1329-32. PubMed ID: 20709051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars.
    Marinković N; Pasalić D; Grsković B; Ferencak G; Honović L; Rukavina AS
    Coll Antropol; 2008 Sep; 32(3):725-9. PubMed ID: 18982743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal jaundice and bilirubin UDP-glucuronosyl transferase 1A1 gene polymorphism in Turkish patients.
    Babaoglu MO; Yigit S; Aynacioglu AS; Kerb R; Yurdakok M; Bozkurt A
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):377-80. PubMed ID: 16623861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients.
    Dabke PS; Colah RB; Ghosh KK; Nadkarni AH
    Hematology; 2014 Oct; 19(7):388-92. PubMed ID: 24620945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.
    de Vries HS; Te Morsche RH; Jenniskens K; Peters WH; de Jong DJ
    J Crohns Colitis; 2012 Jun; 6(5):597-602. PubMed ID: 22398043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
    Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie PI; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO
    Pharmacogenet Genomics; 2006 May; 16(5):321-9. PubMed ID: 16609363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.